This study focuses on an eco-friendly and cost-effective green synthesis of zinc oxide nanoparticles using the aqueous leaf extract of Ehretia cymosa as a natural capping and stabilizing agent, combined with zinc acetate dihydrate as a precursor. Synthesis was conducted across various volumetric precursor-to-extract ratios (1:1, 1:2, and 1:3 v/v) at pH 12, followed by thermal annealing at 500°C. X-ray diffraction analysis confirmed the formation of phase-pure, highly crystalline ZnO NPs featuring a hexagonal wurtzite crystal structure. Based on the Debye-Scherrer equation, the calculated average crystallite sizes were 17.84 nm for the 1:1 ratio and 18.25 nm for the 1:3 ratio. The smaller particle size observed in the 1:1 formulation is attributed to higher concentrations of phytochemical capping agents that prevented nanoparticle aggregation. The antibacterial efficacy of the synthesized ZnO NPs was evaluated against Gram-negative ( Escherichia coli ) and Gram-positive ( Staphylococcus aureus ) bacterial strains using the disc diffusion method. The nanoparticles exhibited strong, dose-dependent antibacterial activity against both pathogens. Higher antibacterial susceptibility was observed in S. aureus (26 mm inhibition zone at 0.04 mg/mL) compared to E. coli (25 mm inhibition zone at 0.04 mg/mL). This differential sensitivity is linked to structural variations in their cell walls, as the outer membrane of Gram-negative bacteria acts as a partial permeability barrier. Generally, Ehretia cymosa leaf extract provides a sustainable biological platform for producing functional ZnO nanomaterials with effective antimicrobial properties.
No takes yet. Share an insight, caveat, or question.
Ashetu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: